Ultragenyx Pharmaceutical (RARE) Profit Margin (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) profit margin from Mar 31, 2013 to Mar 31, 2026. The current Ultragenyx Pharmaceutical (RARE) profit margin is -136.03%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Ultragenyx Pharmaceutical (RARE)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -85.44% | -15.91% |
| 2024 | -101.61% | -27.35% |
| 2023 | -139.86% | -28.17% |
| 2022 | -194.70% | +50.70% |
| 2021 | -129.20% | +87.69% |
| 2020 | -68.84% | -82.27% |
| 2019 | -388.32% | -11.33% |
| 2019 | -437.95% | +6.65% |
| 2019 | -410.64% | -22.89% |
| 2019 | -532.53% | +38.78% |
| 2018 | -383.71% | -48.32% |
| 2018 | -742.43% | +80.08% |
| 2018 | -412.28% | -245.56% |
| 2018 | 283.24% | -102.45% |
| 2017 | -11576.25% | -70.78% |
| 2017 | -39615.00% | -79.05% |
| 2016 | -189130.77% | N/A |
Comparison Ultragenyx Pharmaceutical (RARE) profit margin with competitors
Ultragenyx Pharmaceutical (RARE) profit margin is -136.03%.